FDX will likely continue to weigh on the broader averages.
Let's see whether this transport's bumpy ride ahead could throw off investors.
We're checking the charts and indicators.
The shares were improving even before recent news out of China about the resumption of group tours, which should help its Macau casino.
Let's review the charts and indicators.
Here's what to avoid for now.
Plus, we take looks at Eli Lilly and Raytheon Technologies after positive news developments for both companies.
Shares of Novavax are looking weak and in need of a booster, according to the technicals.
INTU got a 'Buy' rating, but my view of the charts doesn't jibe with the fundamentalist's.
Shares of the aluminum company are sinking on weak prices and an analyst downgrade.